MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$2,447,831
Unit: Dollar

Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
1,394,569 1,435,135 2,924,607.5* 2,131,444
General and administrative
1,222,974 1,836,817 2,121,189* 1,898,397
Total operating expenses
2,617,543 3,271,952 5,045,796.5 4,029,841
Loss from operations
-2,617,543 -3,271,952 -5,045,796.5* -4,029,841
Gain on remeasurement of warrant liabilities
0 0 114,045* -27,816
Interest expense
2,935 6,653 2,299* 2,605
Interest income
176,319 89,354 188,445* 59,103
Other expense, net
-1,040 -3,390 -20,024* -6,774
Total other income, net
172,344 79,311 280,167* 21,908
Loss before provision for income taxes
-2,445,199 -3,192,641 -4,765,629.5* -4,007,933
Provision for income taxes
2,632 3,346 2,698* 2,840
Net loss
-2,447,831 -3,195,987 -4,768,327.5 -4,010,773
Basic EPS
-0.19 -0.46 0.043 -0.06
Basic Average Shares
13,208,816 7,022,945 -111,649,942 72,685,740
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$2,447,831 (59.56%↑ Y/Y)Interest income$176,319 (671.74%↑ Y/Y)Loss beforeprovision for income taxes-$2,445,199 (59.55%↑ Y/Y)Provision for income taxes$2,632 (-66.91%↓ Y/Y)Total other income,net$172,344 (530.70%↑ Y/Y)Interest expense$2,935 (-38.82%↓ Y/Y)Other expense, net-$1,040 (43.78%↑ Y/Y)Loss from operations-$2,617,543 (56.90%↑ Y/Y)Total operatingexpenses$2,617,543 (-56.90%↓ Y/Y)Research and development$1,394,569 (-62.56%↓ Y/Y)General andadministrative$1,222,974 (-47.92%↓ Y/Y)

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)